Andge Valiakhmetova

Moscow, MOW, Russian Federation

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Molecular heterogeneity of pediatric choroid plexus carcinomas determines the distinctions in clinical course and prognosis.

Molecular heterogeneity of pediatric choroid plexus carcinomas determines the distinctions in clinical course and prognosis.

Journal: Neuro-oncology
Published: December 19, 2022

Supratentorial tumor resembling anaplastic ependymoma in an adolescent.

Supratentorial tumor resembling anaplastic ependymoma in an adolescent.

Journal: Brain pathology (Zurich, Switzerland)
Published: June 22, 2022

Two clinically distinct cases of infant hemispheric glioma carrying ZCCHC8:ROS1 fusion and responding to entrectinib.

Two clinically distinct cases of infant hemispheric glioma carrying ZCCHC8:ROS1 fusion and responding to entrectinib.

Journal: Neuro-oncology
Published: February 23, 2022

Long-term survival of a patient with metastatiс choroid plexus carcinoma, de novo germline TP53 mutated, after craniospinal proton irradiation.

Long-term survival of a patient with metastatiс choroid plexus carcinoma, de novo germline TP53 mutated, after craniospinal proton irradiation.

Journal: Pediatric blood & cancer
Published: October 18, 2021

Methodological Challenges of Digital PCR Detection of the Histone H3 K27M Somatic Variant in Cerebrospinal Fluid.

Methodological Challenges of Digital PCR Detection of the Histone H3 K27M Somatic Variant in Cerebrospinal Fluid.

Journal: Pathology oncology research : POR
Published: August 16, 2021

The experience of successful treatment of ETV6-NTRK3-positive infant glioblastoma with entrectinib.

The experience of successful treatment of ETV6-NTRK3-positive infant glioblastoma with entrectinib.

Journal: Neuro-oncology advances
Published: March 19, 2021

Pediatric diffuse leptomeningeal glioneuronal tumor: Two clinical cases of successful targeted therapy.

Pediatric diffuse leptomeningeal glioneuronal tumor: Two clinical cases of successful targeted therapy.

Journal: Pediatric blood & cancer
Published: March 20, 2020

Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2-Year Durable Response.

Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2-Year Durable Response.

Journal: The oncologist
Published: August 06, 2019
Showing 1-8 of 8

Last Updated: 09/26/2026